Healthcare -
Biotechnology - NASDAQ - US
$ 17.37
-0.934 %
$ 2.18 B
Market Cap
-11.27
P/E
APLS - CASH FROM OPERATIONS
Cash from Operations APLS - Apellis Pharmaceuticals, Inc.
-87.9 M
LAST VALUE
58.64%
2 YEAR CAGR
16.08%
5 YEAR CAGR
-24.34%
10 YEAR CAGR